Setbacks In Patients With Relapsing-Remitting Multiple Sclerosis Can Be Reduced If Methylprednisolone Is Added To Interferon Beta
Links shared publicly online about this topic.
- 2,066total visits
Setbacks In Patients With Relapsing-Remitting Multiple Sclerosis Can Be Reduced If Methylprednisolone Is Added To Interferon Beta
Conclusions reported in an Article published Online first, as well as in the June edition of The Lancet Neurology, and the announcement made at the American Academy of Neurology meeting in
View full resource at medicalnewstoday.com
Tags: Neurology, Multiple Sclerosis, Depo-Medrol, Medrol, Solu-Medrol
Most Recently Shared on May 5, 2009 at 12:04 pm By:
MedNewsToday: Setbacks In Patients With Relapsing-Remitting Multiple Sclerosis Can Be Reduced If Me.. http://tinyurl.com/c8ccfk
Advertisement
